Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis

Clinical trial NCT05133336 · COMPLETED

Trial details

NCT number: NCT05133336
Sponsor: Zydus Therapeutics Inc.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Primary Biliary Cholangitis

Start date: 2022-04-01
Primary completion: 2025-04-30
Enrollment: 196

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.